A detailed history of Brewin Dolphin Wealth Management LTD transactions in Organon & Co. stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 178 shares of OGN stock, worth $2,687. This represents 0.0% of its overall portfolio holdings.

Number of Shares
178
Previous 178 -0.0%
Holding current value
$2,687
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Nov 14, 2022

BUY
$28.67 - $37.13 $5,103 - $6,609
178 New
178 $5,000
Q3 2021

Nov 09, 2023

SELL
$28.63 - $35.64 $3,321 - $4,134
-116 Reduced 32.77%
238 $7.8 Million
Q2 2021

Nov 09, 2023

BUY
$28.45 - $38.0 $5,007 - $6,688
176 Added 98.88%
354 $10.7 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.84B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.